Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2019
Oyster Point Pharma announces proposed IPO filing
Oyster Point Pharma announced that it had filed a Form S-1 registration statement with the SEC for a proposed initial public offering. The share count and price range had not yet been determined, and the offering was subject to conditions.